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Purpose of review
It has been a long lasting question that although a similar peripheral allergen-specific
immune response has been observed, why do some patients show only atopic
dermatitis, rhinitis and asthma alone or their combinations? The answer resides in the
propensity of resident tissue cells and local antigen-presenting cells and T cells for
developing an allergic inflammatory immune response. Antigen-presenting cells
introduce processed allergens to T helper lymphocytes, where a decision of developing
different types of T cell immunity is given under the influence of several cytokines,
chemokines, costimulatory signals and regulatory T cells.
Recent findings
We focused in this review article on effector T cell subsets, which have been
recently described such as Th9, Th17 cells and Th22 cells, which are characterized by
their IL-9 and IL-10, IL-17 (or IL-17A) and IL-22 expression, respectively together with
other proinflammatory cytokines, which coordinate local tissue inflammation. Both
naturally occurring CD4þCD25þ regulatory T (Treg) cells and inducible populations of
allergen-specific, IL-10-secreting Treg type 1 cells inhibit allergen-specific effector cells
and have been shown to play a central role in the maintenance of peripheral
homeostasis and the establishment of controlled immune responses in allergic
inflammatory tissues.
Summary
Better understanding and characterization of newly described effector cell subsets and
their interaction between antigen presenting cells and resident tissue cells will enlighten
our knowledge on the mechanisms of allergic diseases.
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1528-4050Introduction
Major causative factors added to the genetic propensity of
developing IgE antibodies responsible for symptoms and
signs of allergic disorders [1] can be listed as encounter
with various new molecules in air, water and diet, and
living in a more polluted world with less exposure to
infections and infectious agents. Clinical manifestations
are allergic rhinitis, allergic asthma, food allergy, allergic
skin inflammation, ocular allergy, as single or combined
disease [2]. Biochemical properties of the allergen, sti-
mulating factors of the innate immune response around
the allergen substances at the time of exposure, stability
of the allergen in the tissues, digestive system, skin or
mucosa, and the dose and time of stay in lymphatic organs
during the interaction with the immune system are all
possible confounding factors causing an antigen to
become an allergen [2]. Antigen specificity in an evolved
response of both T and B-lymphocytes takes part inopyright © Lippincott Williams & Wilkins. Unauth
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sible for cell-mediated immune responses, where B-
lymphocytes are for humoral immune responses [3].
Two essential factors of adaptive immunity are specificity
and memory, which is determined by the existing fre-
quency of circulating T and B cells and readiness to
respond to antigens.
Dendritic cells are complex cell populations that differ in
their anatomic location, antigen recognition, processing
machinery, and migratory capacity. Dendritic cells stay as
sentinels that take up exogenous antigens and transmit
the information into the immune system by migrating to
draining lymph nodes, and presenting the processed
antigens to T cells resulting in T-cell differentiation
and activation [4,5]. Content of micromillieu and several
cytokines and other cofactors released from dendritic
cells are essential for the differentiation of naive T cells
into T helper (Th)1, Th2, Th9, Th17 and Th22 effectororized reproduction of this article is prohibited.
DOI:10.1097/ACI.0b013e32833d7d48
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cells results in production of IL-4 and IL-13, which
induce immunoglobulin class switching to IgE and clonal
expansion of naive and IgEþmemory B-cell populations.
When IgE bound to FceRI (high-affinity receptor for
IgE) on mast cells and basophils crosslinks with the
specific allergen, release of vasoactive amines (such as
histamine), lipid mediators, chemokines and cytokines
occur, which are responsible for the signs and symptoms
of immediate phase of the allergic reactions [7]. This
mast cell or basophil degranulation should be very
important for the development of further Th2 responses
because basophil IL-4 has been shown to be essential in
their differentiation [8,9].
Atopic dermatitis (AD) patients possess increased num-
bers of activated cutaneous lymphocyte-associated anti-
gen (CLA)-bearing T cells in the circulation and
increased levels of serum L-selectin, a marker for leu-
kocyte activation correlating with atopic dermatitis dis-
ease severity [10–12]. CLA defines a subset of circulating
memory T cells that selectively localizes to cutaneous
sites. CLAþ T cells constitute only 10–15% of the
circulating T-cell pool and do not exceed 5% of lympho-
cytes within noncutaneous inflamed sites [13]. CLA is
expressed on Th1 cells during the differentiation process
and can be induced on Th2 cells by stimulation with
bacterial superantigen and/or IL-12 [14,15]. Improve-
ment in eczematous skin lesions seen in primary T-cell
immunodeficiency disorders after successful bone mar-
row transplantation also remarks for the key role of
immune effector T cells in atopic dermatitis. Dermal
cellular infiltrate in atopic dermatitis mainly consists of
CD4þ and CD8þ T cells with a CD4/CD8 ratio similar
to peripheral blood levels [16,17]. In studies [16,17],
CD8þCLAþ T cells were demonstrated to be as potent
as CD4þCLAþT cells in induction of IgE and inhibition
of eosinophil survival.
The role of aeroallergens in T cell activation in atopic
dermatitis has been extensively studied [18,19]. Aero-
allergens can induce both immediate type and delayed
type responses in the skin [19]. The frequency of aero-
allergen-specific T cells was found to be less than 1% in
nonchallenged atopic dermatitis lesions [20]. In addition,
such allergen-specific T cells can be detected in the skin
of atopic patients after allergen administration, without
any signs of atopic dermatitis lesions [21]. The contri-
bution of food allergens in the exacerbation of atopic
dermatitis by T cell activation was also demonstrated
[22]. It has recently been demonstrated that allergens
such as house dust mite (Dermatophagoides pteronyssinus)
and birch pollen induce atopy patch test reactivity in
NAD patients with the presence of specific IgG, but not
IgE antibodies [23]. Normally allergen-specific T cell
responses in food and aeroallergen allergy are confined toopyright © Lippincott Williams & Wilkins. UnauthoCD4þ T cells. This, however, may not explain the
activation and recruitment of CD8þ T cells in atopic
dermatitis skin lesions. It is also known that bacterial
superantigens can interact with certain Vb elements of
the T cell receptor (TCR) leading to activation, expan-
sion, anergy or deletion of T cells. It is evident from
mouse studies that superantigen response of T cells is not
restricted to CD4þ T cells. CD8þ T cells [24] and even
CD4 CD8 T cells can respond to superantigenic
stimuli [25]. This may explain the existence and acti-
vation of CD8þ T cells in eczema lesions and their
contribution to IgE production and eosinophil survival
and development, chronicity and exacerbation of atopic
dermatitis [16,17]. One of the factors that may contribute
to the pathophysiology of atopic dermatitis is autoreac-
tivity to human proteins [26,27]. IgE against autoantigens
can stimulate type 1 hypersensitivity reactions and den-
dritic cells, and induce the proliferation of autoreactive
T cells [28]. Another widely supported view is that
dermal dendritic cells and epidermal Langerhans cells
display an abnormal hyperstimulatory function for T cells,
in addition to IL-12 and IL-18 production. IgE FceRI and
FceRII (CD23) are upregulated in CD1a positive cells in
atopic dermatitis. CD1a is a marker of dermal dendritic
cells and Langerhans cells [29].Allergen recognition by the immune system
Dendritic cells play roles in the induction of protective
T cell immunity, as well as in tolerance induction. The
two distinct dendritic cell subsets that have been recog-
nized in humans are myeloid dendritic cells (mDCs) and
plasmacytoid dendritic cells (pDCs) [30]. Myeloid den-
dritic cells express TLR2–TLR6 and TLR8 and can
produce IL-12 in response to thebacterial andviral stimuli,
whereas pDCs express TLR7 and TLR9 and have the
ability to produce large amounts of type 1 interferons in
antiviral immune responses [31–34]. It has been suggested
that pDCs directly suppress the potential of mDCs to
generate effector T cells [35]. It was reported that pDCs
could stimulate the formation of Treg cells, possibly in an
ICOS-L-dependent way [32,35]. Depletion of pDCs from
the lungs has abolished tolerance to inhaled antigens
[35,36]. On the contrary, the two distinct dendritic cell
populations that have been identified in inflamed epider-
mis of atopic dermatitis are the classical Langerhans cells
and the inflammatory dendritic epidermal cells (IDEC)
[37]. IDEC population clearly induces a Th1 profile,
whereas Langerhans cell population rather induces a
Th2 type of T-cell response [38]. Concerning dendritic
cells and Langerhans cells, the expression of IgE FceRI
and its increase on the surface of these cells is strongly
related to distinct type of inflammatory status [39].
Tissue-resident mast cells are important in allergic dis-
eases. In a mouse model of allergic airways inflammation,rized reproduction of this article is prohibited.
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with increased concentrations of the chemokine CCL2 in
the lungs. Mast cell progenitors (MCps) arising in bone
marrow are recruited to tissues by transendothelial mig-
ration, and CCL2 was chemotactic for MCps, suggesting
a complex role of the CCL2/CCR2 axis in recruiting
MCps during pulmonary inflammation [40]. Recently,
it was shown that Znt5 is selectively required for the mast
cell-mediated delayed-type allergic response, and Zinc
(Zn) is a novel player in mast cell activation [41].
Recent research has substantially expanded our view on
the function of natural killer (NK) cells in the immune
system. In patients with allergic diseases, the production
of Th2 cytokines by NK cells contributes to the known
immune deviation [42,43]. It was also shown that NK
cells affect skin immune responses to haptens by releas-
ing type 1 cytokines and inducing keratinocyte apoptosis.
More than 90% of NK cells isolated from allergic contact
dermatitis skin showed a CD3–CD56 (high) CD16-
phenotype. Skin NK lymphocytes displayed a CXCR3þ
CCR6þCDR5þ chemokine receptor asset for homing
into inflamed skin, but not CD62L and CCR7 for lymph
node homing. Those findings underline the importanceopyright © Lippincott Williams & Wilkins. Unauth
Figure 1 Differentiation of effector T cells depending of the adjuvan
the cells and cytokines in the microenvironment – naı¨ve T cells ca
On the basis of their respective cytokine profiles, responses to chemokines an
types of inflammatory responses.of the interaction between innate and adaptive immune
mechanisms for amplification of skin allergic responses to
haptens and full expression of allergic contact dermatitis
[44].Effector T cell subsets
Activated effector T cells play an essential role in allergy
and asthma and other inflammatory diseases (Fig. 1).Th1 and Th2 cells
Formerly, subsets of CD4þ Th lymphocytes were cate-
gorized as Th1 and Th2 based on their distinct cellular
functions and cytokine secretion capacities [45]. Our
knowledge of the pathogenesis of atopic diseases has
broadened to incorporate the contribution of Treg cells
and the newly described proinflammatory Th9, Th17,
and Th22 cell lineages. The commitment of peripheral
T-cell clones to undergo differentiation into one of those
lineages is controlled by key transcriptional regulators:
T-box expressed in T cells (Th1), GATA-3 (Th2), fork-
head box p3 (FOXP3, Treg cells), retinoid-related orphan
receptor gt/retinoid-related orphan receptor a (Th17)orized reproduction of this article is prohibited.
icity of the substances coexposed with the antigen and status of
n differentiate into Th1, Th2, Th9, Th17, and Th22 types of cells
d interactions with other cells, these T-cell subsets can promote different
C446 Skin allergyand ETS family member PU.1 (Th9) [46,47]. Counter-
regulation between these effector subsets has been con-
tinuously proposed [48–51]. The activation of T-bet as a
key transcription factor of Th1 cells inhibits both Th2
cell-mediated eosinophil recruitment and Th17 cell-
mediated neutrophil recruitment into the airways [52].
An association between a specific T-bet haplotype and
allergic asthma in children is demonstrated [53].
Predominant Th2 profile in atopic diseases might be a
result of the increased tendency to activation and apop-
tosis of high IFN-g-producing Th1 cells [54]. Th1 cells,
particularly their high IFN-g-producing fraction, and
CXCR3þ T cells showed significantly increased apopto-
sis in atopic individuals [54]. Th1 cells are implicated in
cell-mediated defence against intracellular microorgan-
isms and in promotion of memory IgG responses and are
characterized by IL-2, interferon (IFN)-g and TNF-b
cytokine profiles. These cells can efficiently contribute to
the effector phases in allergic diseases by exerting their
roles in apoptosis of the epithelium in asthma and atopic
dermatitis [55,56]. It was shown that dysregulated apop-
tosis in skin-homing T cells and keratinocytes contri-
butes to the elicitation and progress of atopic dermatitis.
T cell survival is enhanced in the skin by cytokines and
extracellular-matrix proteins [57]. These activated T cells
induce keratinocyte apoptosis, leading to eczema for-
mation [58]. A new study [59] demonstrated that IL-
32 as a new cytokine is expressed by human primary
keratinocytes and modulates keratinocyte apoptosis and
might also play a role in the formation andmaintenance of
atopic dermatitis lesions. IL-27 has been described to
support T cell-polarization along the Th1 lineage but also
to exert important anti-inflammatory responses in later
phases of inflammation in murine models. IL-27 also acts
as a priming signal on keratinocytes able to amplify che-
mokine production and surfacemolecule expression when
used before a second signal, such as TNF-alpha. The
effect of IL-27 could not be mimicked by IL-6, IL-12
or IL-23 and IL-27might act in an inflammatory, diseases-
maintaining manner in the epidermal compartment of
patients with eczema [60].
Th2 cells engage in immunity to parasites, secrete IL-4,
IL-5 and IL-13 andpredominantlymediate IgE responses,
eosinophilia and allergic inflammation [7,61]. IL-4 plays an
important role in regulating epidermal homeostasis and
innate barrier function [62]. It has been shown that OX40
ligation upregulates IL-4 production which promotes Th2
polarization [63]. Thymic stromal lymphopoietin (TSLP)
as a novel growth factor is produced by epithelial cells and
has master roles at the epithelial cell and dendritic cell
interface of allergic inflammation [64]. TSLP has been
suggested to activate human mDCs to induce inflamma-
tory Th2 responses [65]. TSLP-induced dendritic cells
mature and migrate into the draining lymph nodes toopyright © Lippincott Williams & Wilkins. Unauthoinitiate the adaptive phase of allergic immune response.
TSLP-induced dendritic cells express OX40L, which
triggers the differentiation of allergen-specific naive
CD4þ T cells to inflammatory Th2 cells [66]. IL-25
(IL-17E), a member of the IL-17 family of immunoregu-
latory cytokines, has been implicated in the regulation of
Th2 type immunity [67]. Blocking IL-25 in an experimen-
tal model of allergic asthma prevented AHR and reduced
IL-5 and IL-13 production, eosinophil infiltration, goblet
cell hyperplasia, and serum IgE secretion [68]. IL-33, a
recently discovered cytokine, is a potent inducer of Th2
type responses via its receptor ST2 [69]. In-vitro polarized
Th2 cells produce enhanced amounts of Th2 type cyto-
kines in the presence of IL-33. Over-expression of IL-33
leads to spontaneous pulmonary inflammation in mIL-33
transgenic mice [70].Th17 cells
Th17 cells and their prototype cytokines IL-17A coordi-
nate local tissue inflammation through upregulation of
proinflammatory cytokines and chemokines [71,72]. Epi-
cutaneous sensitization in the absence of IL-4/IL-13
induces an exaggerated Th17 response systemically and
in lungs after antigen challenge that results in airway
inflammationandairwayhyperresponsiveness [73].Differ-
entiation of Th17 (IL-17A-producing and IL-17F-produ-
cing) cells is induced by IL-1b, IL-6, IL-21, IL-23, and
TGF-b [6]. IL-17 act as a recruitment and survival factor
for macrophages and coordinate granulocyte influx in
allergic airway inflammationmodels [74,75]. Vaccinia virus
inoculation in OVA-sensitized skin induced marked local
expression of IL-17 transcripts and massive neutrophil
infiltration. Treatment with anti-IL-17 decreased the size
of primary lesions, numbers of satellite lesions and viral
loads.Thesefindings suggest that IL-17maybe apotential
therapeutic target in eczema vaccinatum [76]. There are
also pharmacological measures to manipulate these Th
subsets. Prostaglandin E2 (PGE2) acts on its receptor EP4
on T cells and dendritic cell not only facilitates Th1 cell
differentiation but also amplifies IL-23-mediated Th17
cells in regional lymph nodes and suppresses the disease
progression in mice subjected to experimental auto-
immune encephalomyelitis or contact hypersensitivity.
Thus, PGE2-EP4 signaling promotes immune inflam-
mation through Th1 differentiation and Th17 expansion,
and EP4 antagonism may be therapeutically useful for
various immune diseases [77].Th9 and Th22 cells
More recently, another two subsets of effector CD4þTh
cells, named Th9 and Th22 cells, have been described,
even if their pathophysiological meaning is still unclear.
Recent comparative analysis of different subsets of
T helper cells for cytokine production revealed thatrized reproduction of this article is prohibited.
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and IL-4 significantly enhances IL-9 and IL-10 pro-
duction but not other Th2 cytokines, indicating that
IL-9-producing cells are not Th2 cells [78,79] suggesting
that they represent a new subset of T helper cells with
the transcription factor PU.1 [47]. Functional analysis of
Th9 cells has also confirmed that in contrast to Treg cells,
Th9 are neither anergic nor suppressive, as they can
vigorously proliferate and along with effector T cells
they further enhance T-cell proliferation [78]. Studies
in allergic patients has revealed that T cells can be a
significant source of IL-9 and mouse models have
revealed that IL-9 has multiple effects in the develop-
ment and maintenance of allergic inflammation and air-
way remodeling. It is as yet unknown whether IL-9-
secreting T cells are distinct from Th2 cells or whether
Th2 cells can be reprogrammed into Th9 cells during the
allergic response in vivo [80].
A less well defined tissue-instructing cytokine is IL-22.
Recent studies [81,82]havedeterminedthat someTcells
express IL-22 independently of IL-17, particularly
CCR10þ T cells. IL-22 belongs to the IL-10 cytokine
family and binds to a heterodimeric receptor consisting
of the IL10 receptor (IL-10R)b chain and the IL-22R [83].
The IL-22R is expressed almost exclusively on nonim-
munecells, suggesting that IL-22, likeIL-17,actsprimarily
on tissue cells [83]. It is consistently described to enable
epithelial innate immune responses, which can be detri-
mental or protective. In a recent study [84], it was shown
thatTh22 clones derived frompatients with psoriasis were
stable in culture and exhibited a transcriptome profile
clearly separate from those of Th1, Th2, and Th17 cells;
it included genes encoding proteins involved in tissue
remodeling and chemokines involved in angiogenesis
and fibrosis.
In another study [85], the ability of cutaneous resident
dendritic cells to differentiate IL-22-producing cells was
investigated. Indeed, both Langerhans cells and dermal
dendritic cells significantly induced IL-22-producing
CD4(þ) andCD8(þ) T cells fromperipheral bloodT cells
and naive CD4(þ) T cells in mixed leukocyte reactions.
Surprisingly, themajorityof IL-22-producingcells induced
by Langerhans cells and dermal dendritic cells lacked the
expression of IL-17, IFN-g, and IL-4. Thus, Langerhans
cells and dermal dendritic cells preferentially induced
helperT cells to produce only IL-22, possibly ‘Th22’ cells.
Data indicate that cutaneous dendritic cells, especially
Langerhans cells, may control the generation of distinct
IL-22 producing Th22 cells infiltrating into the skin.Regulatory T cells
Subsets of Treg cells with distinct phenotypes and
mechanisms of action include the naturally occurring,opyright © Lippincott Williams & Wilkins. Unauththymus-selected CD4þCD25þ Forkhead box protein 3
(FOXP3)þ Treg cells and the inducible type 1 IL-10-
secreting Treg cells (TR1 cells) [86]. Additionally, sub-
sets of CD8þ T cells, gd T cells, dendritic cells, IL-10-
producing B cells, NK cells and resident tissue cells,
which might promote the generation of Treg cells, could
contribute to suppressive and regulatory events [87].
Treg cells induce an abolished allergen-specific T-cell
proliferation and suppressed Th1 and Th2 type cytokine
secretion. In addition, Treg cells directly or indirectly
suppress effector cells of allergic inflammation such as
mast cells, basophils and eosinophils [88,89] (Fig. 2).
Moreover, Treg cells can potently suppress IgE pro-
duction, whereas simultaneously increasing production
of noninflammatory isotypes IgG4 and IgA, respectively
[88]. Several studies in humans have demonstrated that
in healthy individuals, if an immune response to common
environmental allergens is detectable, TR1 cells specific
for such allergens represent the dominant subset [88,90–
92]. Both healthy and allergic individuals display aller-
gen-specific Th1, Th2 and TR1 cells that recognize the
same T cell epitopes. Accordingly, depending on the
predominant subset and the balance between Th2 and
TR1 cells the individuals may develop allergy (Th2
predominance) or recovery (TR1 predominance). Simi-
larly repeated exposure of nonallergic healthy bee-
keepers to bee venom allergens during the beekeeping
season via skin represents a valuable model to ascertain
mechanisms of T-cell tolerance induction. After multiple
bee stings, venom antigen-specific Th1 and Th2 cells
show clonal switch toward IL-10-secreting TR1 cells and
impair capacity of allergen-specific T cells to proliferate
and produce Th1 and Th2 cytokines. This regulation
continues as long as venom exposure persists reaching
initial levels within 2–3 months after bee stings [91].
The immune regulatory role of T cell-derived IL-10
in allergic disease has been extensively studied. IL-10-
treated dendritic cells are potent suppressors of the devel-
opment of AHR, inflammation, and Th2 cytokine pro-
duction; these regulatory functions are at least in part
through the induction of endogenous production of IL-
10 [93]. IL-10 inhibitsCD28and ICOScostimulationsofT
cells via src homology 2 domain-containing protein tyro-
sine phosphatase (SHP)-1 [94]. Accordingly, spleen cells
fromSHP-1-deficientmice showed increased proliferation
withCD28 and ICOS stimulation in comparisonwithwild-
type mice. In conclusion, the rapid inhibition of the
CD2, CD28 or ICOS costimulatory pathways by SHP-1
represents a novelmechanism fordirectT-cell suppression
by IL-10 [94]. Immunohistochemical analyses of lesional
skin biopsies of atopic dermatitis patients revealed the
presence of IL-10-secreting Tr1 cells, but not FoxP3þ
CD4þCD25þT cells [95]. Devoid of functional Treg cells
in acute infiltrates in atopic dermatitis skin lesions suggest
an imbalance in T-cell regulation [95].orized reproduction of this article is prohibited.
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Figure 2 The role of T regulatory cells and allergic diseases
Treg cells have immunosuppressive functions and cytokine profiles distinct from that of either Th1 or Th2 cells. Regulatory T cells are classified as
naturally occurring and inducible Treg cells. Treg cell response is characterized by an abolished allergen-specific T cell proliferation and the
suppressed secretion of Th1 and Th2 type cytokines. Treg cells are able to inhibit the development of allergen specific Th2 and Th1 cell responses
and therefore play an important role in healthy immune response to allergens. Treg cells potently suppress IgE production and directly or indirectly
suppress the activity of effector cells of allergic inflammation, such as eosinophils, basophils andmast cells. In patients with atopic dermatitis, there is
an increased pool of circulating regulatory T cells. Skin biopsies atopic dermatitis patients also revealed overexpression of IL-10 and TGF-b, but not
CD4þCD25þ.In addition to IL-10, TGF-b is a key cytokine in immune
tolerance. It was demonstrated that orally administered
TGF-b, such as TGF-b in humanmilk, retains and exerts
its activity in the intestinal mucosa and can induce
immune tolerance to dietary antigens. BALB/c mice
treated orally with OVA and TGF-b showed augmented
reduction of OVA-specific IgE and IgG1 antibodies, T-
cell reactivity, and immediate-type skin reactions when
compared with the mice treated orally with OVA alone
[96]. The data suggest that oral administration of TGF-b
might become a potential strategy to prevent allergic
diseases, such as food allergy. The molecular mechanism
of induction of FOXP3 in human Treg cells has been a
long lasting question. Transforming growth factor-b
(TGF-b) induces the expression of the Runt-related
transcription factors RUNX1 and RUNX3 in CD4þ
T cells [97]. This induction seems to be a prerequisite
for the binding of RUNX1 and RUNX3 to FOXP3 pro-
moter. Inactivation of the gene encoding RUNX by small
interfering RNA (siRNA)-mediated suppression of
RUNX1andRUNX3 inhumanTcells resulted in reduced
expression of Foxp3 demonstrating Runx transcription
factors as a molecular link in TGF-b-induced Foxp3
expression in iT reg cell differentiation and function.opyright © Lippincott Williams & Wilkins. UnauthoConclusion
Understanding the mechanisms enrolled in the develop-
ment of tissue specific allergic diseases are essential to
develop strategies for treatment and prevention. Skin and
mucosal epithelial cell organization shows a significant
difference, which is decisive in the initiation of early
stages of allergic infiltration and maintenance of chroni-
city. Different capture and recognition of antigens take
place in different allergic tissues due to tissue specific
antigen-presenting cells with highly distinctive features
acting for introduction to the immune effector cells,
especially to T lymphocytes. Recent developments in
T-cell subsets, particularly the extension of the know-
ledge on reciprocal-regulation and counter-balance
between Th1 and Th2 cells to Th9, Th17, Th22 and
Treg cells has increased our knowledge in mechanisms of
immune regulation. Differences of chemokines and
organ-selective migration of the inflammatory cells is
another decisive factor for selection of tissues. In
addition, frequency of mast cells, proinflammatory
macrophages, propensity of subepithelial fibrocytes are
factors that may contribute but still remain to be
elucidated.rized reproduction of this article is prohibited.
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